SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-19-004633
Filing Date
2019-04-24
Accepted
2019-04-24 16:31:06
Documents
3
Period of Report
2019-06-18
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2019def14a.htm DEF 14A 539705
2 a12417corceptproxycard20001.jpg GRAPHIC 169588
3 a12417corceptproxycard20002.jpg GRAPHIC 149279
  Complete submission text file 0001628280-19-004633.txt   980094
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 19764214
SIC: 2834 Pharmaceutical Preparations